Is secretory IgA the dominant antibody at intestinal mucosal surfaces and increased during antigen-driven mucosal activation?

Secretory IgA (sIgA) represents the first line of adaptive defense at mucosal surfaces. As the dominant immunoglobulin in the human gut, it plays a vital role in protecting the mucosal barrier, neutralizing pathogens, and maintaining homeostasis with the resident microbiota.

Mucosal dominance of Secretory IgA

• Abundance in mucosal secretions: Extensive immunological research confirms that sIgA is the most abundant immunoglobulin isotype at intestinal mucosal surfaces, far exceeding concentrations of IgG and IgM under homeostatic conditions.
• Distribution of plasma cells: Approximately 80% of the body's antibody-secreting plasma cells reside in the intestinal lamina propria, primarily dedicated to the production of dimeric IgA.
• Epithelial transport mechanism: Dimeric IgA is actively transported across the intestinal epithelial barrier via transcytosis mediated by the polymeric Ig receptor (pIgR). The receptor is cleaved at the apical surface, leaving a secretory component attached to the IgA molecule, which protects it from proteolytic degradation in the harsh luminal environment.

Response to immune activation

• Antigen-driven upregulation: Active, ongoing antigen-driven mucosal immune activation—triggered by enteric pathogens, mucosal vaccines, or specific dietary antigens—directly stimulates lamina propria plasma cells, leading to increased local synthesis and secretion of sIgA.
• Immune exclusion: Elevated sIgA acts to coat and neutralize luminal antigens, preventing their adherence to and penetration of the intestinal epithelium.
• Biomarker considerations: While sIgA levels rise during active mucosal immune responses, the clinical utility of total fecal sIgA remains context-dependent. For example, in celiac disease (an antigen-driven enteropathy), while mucosal IgA deposition occurs and serum IgA autoantibodies are diagnostic, fecal sIgA is not a validated biomarker for monitoring gluten exposure or disease activity.

Bottom line

Secretory IgA is the predominant antibody localized at intestinal mucosal surfaces, and its secretion increases dynamically during ongoing antigen-driven mucosal immune activation to maintain barrier integrity and facilitate immune exclusion.